24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Medical
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
15:24
China’s AI sector thrives despite U.S. sanctions on advanced chips
14:46
The great disconnect: Why workers are more disengaged than ever
14:35
"The most strategic country in the world": Singapore is doubling down on Israeli tech
14:00
Israeli high-tech defies odds, raising $9.58 billion in 2024
More stories
Buzz
Most popular
Daily
Weekly
1
The biggest Seed rounds in Israeli tech in 2024
2
"The most strategic country in the world": Singapore is doubling down on Israeli tech
3
TechAir flights from Israel to New York take off January 21
4
From near-death in Gaza to a $100 million exit: Itamar Ben Hemo’s extraordinary journey
5
Defense tech is booming—but who will actually win?
More news
Medical
20 stories about Medical
Cannabis Company Therapix Biosciences to Raise $2.25 Million in Direct Offering
28.03.19
|
Lilach Baumer
In December, Israel-based Therapix scrapped a deal to be acquired by Canadian FSD Pharma for $48 million worth of FSD stock
Cell Immunotherapy Company Enlivex Merges With Nasdaq-Listed Bioblast, Raises $5.3 Million
28.03.19
|
Lilach Baumer
The merged entity listed on Nasdaq under the ticker “ENLV”
Teva Settles Patent Litigation Case for Blood Sugar Stabilizer With Novo Nordisk
24.03.19
|
CTech
Under the settlement agreement, Teva will be able to sell a generic version of the drug as of 2023
Israel Hopping on the Opiate Regulation Wagon
17.03.19
|
Adrian Filut
The Israeli health ministry is setting up a task force to examine current regulation, with the intention of halting the increasingly frequent prescription of opiates in the country
Cannabis Company InterCure Sells Part of Regenera Pharma Stake
11.03.19
|
Tzally Greenberg
InterCure will sell 1.35% of Regenera for a profit of almost $1 million, leaving it with a 12.27% stake
Tower Semiconductor Announces Medical Chip Development With Chinese Biotech Company Axbio
06.03.19
|
Hezi Sternlicht
Tower stated the device, which is intended for blood test analyses, is planned to go into production in mid-2019
Life Sciences Venture Fund aMoon Closes Second Fund at $660 Million
06.03.19
|
Hagar Ravet
The second fund will focus on mid to late-stage health companies in the domains of pharma, digital health, and medical technology
Itamar Medical Starts Trading ADS on Nasdaq
27.02.19
|
Lilach Baumer
The Tel Aviv-listed medical diagnosis company received SEC approval for listing its ADS on the American exchange
Micro Endoscope Developer Zsquare Raises $10 Million
27.02.19
|
Lilach Baumer
The Israel-headquartered company intends to use the funding to apply for FDA approval
Cancer Freezing Company IceCure Raises Just Third of Planned Offering
21.02.19
|
Tzally Greenberg
IceCure develops an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor, freezing its tissue
Genetic Interpretation Startup Emedgene Raises $6 Million
20.02.19
|
Lilach Baumer
Emedgene develops a technology that automates the analysis and interpretation of genetic information at scale
Cannabis Outfit Recruits Israeli Nobel Laureate for Board
17.02.19
|
Tzally Greenberg
Cannabis-based pharma company Panaxia, which is set to merge with Tel Aviv-listed shelf company Herodium, announced Israeli biologist Aaron Ciechanover will join its board
Microsoft Launches Medical AI Service
11.02.19
|
Adi Pick
The service, intended to enable healthcare organizations to build and deploy AI-powered virtual assistants and chatbots, was spearheaded by a team from the company's Israeli research and development center
Teva to Sell Northern Israeli Facility to Private Equity Fund FIMI
06.02.19
|
Tzally Greenberg
Teva unveiled a reorganization plan in December 2017 to ameliorate its debilitating debt, announcing its intention to close or sale facilities and layoff 25% of employees by 2019
Algae-Based Medical Adhesives Developer Sealantis Sold for $25 Million
31.01.19
|
Lilach Baumer
Sealantis uses an algae-based polymer that does not contain proteins, reducing risks of infection or allergic reaction
Healthcare Cybersecurity Startup Medigate Raises $15 Million
29.01.19
|
Meir Orbach
Medigate's technology protects medical devices from cyber attacks once connected to a healthcare provider network
In Tel Aviv, Reform Sends Cannabis Stocks Down as Shareholders Sell High
28.01.19
|
Lilach Baumer
On Sunday, the Israeli government gave the final stamp of approval to a cannabis export reform. In response, Tel Aviv’s cannabis stocks tumbled
Sustained Drug Release Company UroGen Aiming to Raise $150 Million on Nasdaq
24.01.19
|
Lilach Baumer
Goldman Sachs & Co. LLC, JP Morgan, and Jefferies are the joint bookrunners for the offering
New Israeli Medical Technologies Fund Aims to Close $150 Million in Commitments by End of Year
21.01.19
|
Tzally Greenberg
CBG Asset Management, an investment firm owned by U.K.-based businessman Vincent Tchenguiz, is one of the partners in the venture
Struggling InSight Biopharmaceuticals Acquired by Hong Kong’s Gencor Pacific
13.01.19
|
Meir Orbach
In 2017, following financial collapse, the intellectual property and assets of Israel-based InSight were sold to Estonian company PharmaEstica Manufacturing and its Israeli partner
Previous Articles
More Articles
Please ensure Javascript is enabled for purposes of
website accessibility